Literature DB >> 16052036

Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Bronwen Martin1, Rakel Lopez de Maturana, Randall Brenneman, Tom Walent, Mark P Mattson, Stuart Maudsley.   

Abstract

G protein-coupled receptors (GPCRs) play pivotal roles in regulating the function and plasticity of neuronal circuits in the nervous system. Among the myriad of GPCRs expressed in neural cells, class II GPCRs which couples predominantly to the Gs-adenylate cyclase-cAMP signaling pathway, have recently received considerable attention for their involvement in regulating neuronal survival. Neuropeptides that activate class II GPCRs include secretin, glucagon-like peptides (GLP-1 and GLP-2), growth hormone-releasing hormone (GHRH), pituitary adenylate cyclase activating peptide (PACAP), corticotropin-releasing hormone (CRH), vasoactive intestinal peptide (VIP), parathyroid hormone (PTH), and calcitonin-related peptides. Studies of patients and animal and cell culture models, have revealed possible roles for class II GPCRs signaling in the pathogenesis of several prominent neurodegenerative conditions including stroke, Alzheimer's, Parkinson's, and Huntington's diseases. Many of the peptides that activate class II GPCRs promote neuron survival by increasing the resistance of the cells to oxidative, metabolic, and excitotoxic injury. A better understanding of the cellular and molecular mechanisms by which class II GPCRs signaling modulates neuronal survival and plasticity will likely lead to novel therapeutic interventions for neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052036      PMCID: PMC2636744          DOI: 10.1385/nmm:7:1-2:003

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  292 in total

1.  Parathyroid hormone-related protein protects against kainic acid excitotoxicity in rat cerebellar granule cells by regulating L-type channel calcium flux.

Authors:  M L Brines; Z Ling; A E Broadus
Journal:  Neurosci Lett       Date:  1999-10-15       Impact factor: 3.046

2.  Functional antagonism of the human secretin receptor by a recombinant protein encoding the N-terminal ectodomain of the receptor.

Authors:  B K Chow
Journal:  Recept Signal Transduct       Date:  1997

Review 3.  Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse.

Authors:  Shoshana Yakar; Patricia Pennisi; Hong Zhao; Yang Zhang; Derek LeRoith
Journal:  Novartis Found Symp       Date:  2004

Review 4.  Adrenomedullin in the central nervous system.

Authors:  J Serrano; D Alonso; A P Fernández; J M Encinas; J C López; S Castro-Blanco; P Fernández-Vizarra; A Richart; M Santacana; L O Uttenthal; M L Bentura; R Martínez-Murillo; A Martínez; F Cuttitta; J Rodrigo
Journal:  Microsc Res Tech       Date:  2002-04-15       Impact factor: 2.769

5.  A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro.

Authors:  Anne-Marie Lambeir; Paul Proost; Simon Scharpé; Ingrid De Meester
Journal:  Biochem Pharmacol       Date:  2002-12-15       Impact factor: 5.858

6.  Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase.

Authors:  N M Hoosein; R S Gurd
Journal:  FEBS Lett       Date:  1984-12-03       Impact factor: 4.124

7.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

8.  Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).

Authors:  S Gebre-Medhin; H Mulder; M Pekny; G Westermark; J Törnell; P Westermark; F Sundler; B Ahrén; C Betsholtz
Journal:  Biochem Biophys Res Commun       Date:  1998-09-18       Impact factor: 3.575

9.  Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats.

Authors:  T Murase; K Kondo; K Otake; Y Oiso
Journal:  Neuroendocrinology       Date:  1993-06       Impact factor: 4.914

Review 10.  A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin.

Authors:  Mark P Mattson; Stuart Maudsley; Bronwen Martin
Journal:  Ageing Res Rev       Date:  2004-11       Impact factor: 10.895

View more
  37 in total

1.  Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Keely M Murphy; Liping Meng; Janitza Montalvo-Ortiz; Ziling Zeng; Benedict J Kolber; Shanshan Zhang; Louis J Muglia; John G Csernansky
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse?

Authors:  Corey B Smith; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-05-18       Impact factor: 3.444

Review 3.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

4.  Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Authors:  Belén Mollá; Diana C Muñoz-Lasso; Pablo Calap; Angel Fernandez-Vilata; María de la Iglesia-Vaya; Federico V Pallardó; Maria Dolores Moltó; Francesc Palau; Pilar Gonzalez-Cabo
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

5.  An integrated map of corticotropin-releasing hormone signaling pathway.

Authors:  Tejaswini Subbannayya; Lavanya Balakrishnan; Granthali Sudarshan; Jayshree Advani; Santosh Kumar; Riaz Mahmood; Bipin Nair; Ravi Sirdeshmukh; Kanchan K Mukherjee; Sudhir N Umathe; Rajesh Raju; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2013-03-16       Impact factor: 5.782

6.  Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.

Authors:  Hongxin Dong; Shirlene Wang; Ziling Zeng; Fei Li; Janitza Montalvo-Ortiz; Christopher Tucker; Shahzad Akhtar; Jingshan Shi; Herbert Y Meltzer; Kenner C Rice; John G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  2014-05-27       Impact factor: 4.530

Review 7.  Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Chiara M Conti; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

8.  Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?

Authors:  Donald R Staines; Ekua W Brenu; Sonya Marshall-Gradisnik
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression.

Authors:  Bronwen Martin; Yu-Kyong Shin; Caitlin M White; Sunggoan Ji; Wook Kim; Olga D Carlson; Joshua K Napora; Wayne Chadwick; Megan Chapter; James A Waschek; Mark P Mattson; Stuart Maudsley; Josephine M Egan
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

10.  Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure.

Authors:  A Jaferi; D A Lane; V M Pickel
Journal:  Neuroscience       Date:  2009-06-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.